The emergence of mephedrone along with other synthetic cathinones has presented problems for lawmakers and regulatory agencies tasked with controlling the proliferation of recent psychoactive substances. The dynamic character of synthetic drug production, coupled with the flexibility of chemists to modify molecular structures to evade lawful limits